Gene Logic Shares Fall 34 Percent After Company Withdraws 2006, 2007 Guidance | GenomeWeb

NEW YORK, June 22 (GenomeWeb News) - Gene Logic's stock price plummeted 33.7 percent, or $.68, to $1.34 per share in afternoon trading after the company withdrew its previously issued financial guidance for 2006 and 2007.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.